The Role of Cancer-Specific Target Antigens in CAR T Cell Therapy in Hematological Malignancies-Reference-Cited by-同舟云学术

The Role of Cancer-Specific Target Antigens in CAR T Cell Therapy in Hematological Malignancies

Published:2024-02-03 Issue:2 Volume:5 Page:61-67
ISSN:2662-4079
Container-title:Current Tissue Microenvironment Reports
language:en
Short-container-title:Curr. Tissue Microenviron. Rep.

Author:

Khan Tabish H.,Muhammad Naoshad,Tarique Mohammad,Usmani Darksha,Naz Huma,Sarode Aditya

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s43152-024-00055-4.pdf

Reference82 articles.

1. June CH, O’Connor RS, Kawalekar OU, Ghassemi S, Milone MCCA. R. T cell immunotherapy for human cancer. Science. 2018;359:1361–5. Excellent review highlighting the basics of CAR T cell therapy.

2. Sadelain M, Brentjens R, Rivière I. The basic principles of chimeric antigen receptor design. Cancer Discov. 2013;3:388–98. This review provide details of the evolution of the CARs and the requirements for their optimal functioning.

3. June CH, Sadelain M. Chimeric antigen receptor therapy. N Engl J Med. 2018;379(1):64–73.

4. Park JH, Geyer MB, Brentjens RJ. CD19-targeted CAR T cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date. Blood. 2016;127(26):3312–20. Excellent review highlighting the use of CAR T cells to combat hematological malignancies.

5. Park JH, Brentjens RJ. Adoptive immunotherapy for B cell malignancies with autologous chimeric antigen receptor modified tumor targeted T cells. Discov Med. 2010;9(47):277–88.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of ncRNAs and exosomes in the development and progression of endometrial cancer;Frontiers in Oncology;2024-08-12

2. AML cell‐derived exosomes suppress the activation and cytotoxicity of NK cells in AML via PD‐1/PD‐L1 pathway;Cell Biology International;2024-07-19

3. The tumor immune microenvironment and T-cell-related immunotherapies in colorectal cancer;Discover Oncology;2024-06-25

4. Integrated analysis reveals critical cisplatin-resistance regulators E2F7 contributed to tumor progression and metastasis in lung adenocarcinoma;Cancer Cell International;2024-05-17

5. High LGALS3 expression induced by HCP5/hsa-miR-27b-3p correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma;Cancer Cell International;2024-04-20